Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17620948 | 0.79 | TSHR (0.46) | ALDH1A1KMT2AMAPTHTTLMNA | |
| SCHEMBL8919021 | 0.77 | ALDH1A1 (0.35) | ALDH1A1POLBNPSR1TDP1CA14 | |
| SCHEMBL22916912 | 0.76 | FAAH (0.41) | ALDH1A1KMT2APOLBMEN1 | |
| SCHEMBL70980 | 0.75 | ALDH1A1 (0.43) | ALDH1A1KMT2APOLBMAPTHTT | |
| SCHEMBL20034868 | 0.75 | CA2 (0.30) | NPSR1 | |
| SCHEMBL26144797 | 0.72 | KDM4E (0.48) | ALDH1A1 | |
| SCHEMBL26997871 | 0.72 | POLB (0.35) | ALDH1A1KMT2APOLBMAPTHTT | |
| SCHEMBL805360 | 0.72 | ACACB (0.37) | — | |
| SCHEMBL17620947 | 0.71 | ATR (0.36) | — | |
| SCHEMBL19818541 | 0.70 | ALDH1A1 (0.43) | ALDH1A1KMT2APOLBMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018098207-A1 | HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS | CV6 THERAPEUTICS (NI) LIMITED (GB) | 2018-05-31 | — | — | WO | disclosed |